首页|不同入路下行开腹解剖性肝脏切除术治疗肝细胞癌的临床对比

不同入路下行开腹解剖性肝脏切除术治疗肝细胞癌的临床对比

扫码查看
目的 比较不同入路下行开腹解剖性肝脏切除术治疗肝细胞癌的临床效果.方法 纳入2020年1月至2023年1月扬州友好医院收治的64例肝细胞癌患者,依据随机数字表法将患者分为对照组(常规入路下行开腹解剖性肝脏切除术治疗)32例和观察组(沿肝静脉主干入路下行开腹解剖性肝脏切除术)32例.比较两组患者围术期相关指标,术前和术后7 d肝功能指标、免疫功能指标、炎症因子水平,以及术后并发症发生情况.结果 对照组术中出血量为(324.44±76.73)mL,观察组为(250.27±68.64)mL,差异有统计学意义(t=4.075,P<0.05).术后 7 d,对照组 AST、碱性磷酸酶、ALT、总胆红素分别为(73.33±8.23)U/L、(94.44±9.19)U/L、(84.61±8.53)U/L、(24.39±2.64)μmol/L,均高于观察组的(64.52±7.46)U/L、(94.44±9.19)U/L、(73.36±9.58)U/L、(22.14±2.96)μmol/L,差异有统计学意义(P<0.05);术后 3 d,对照组 IgA、IgG、IgM 水平分别为 1.71±0.23、8.31±1.53、1.21±0.28,低于观察组的 1.95±0.24、9.39±1.75、1.35±0.32,差异有统计学意义(P<0.05);术后3 d,对照组血清白细胞介素-6、肿瘤坏死因子-α、C-反应蛋白水平分别为(149.89±30.79)ng/L、(229.15±27.24)ng/L、(28.74±3.26)mg/L,高于观察组的(128.85±20.81)ng/L、(208.11±23.26)ng/L、(22.21±3.44)mg/L,差异有统计学意义(P<0.05);对照组术后并发症总发生率为21.88%(7/32),观察组为15.63%(5/32),差异无统计学意义(x2=0.410,P=0.522).结论 与常规入路相比,采用沿肝静脉主干入路能够减轻开腹解剖性肝脏切除术对肝功能和免疫功能的损伤,减少术中出血量和炎症反应,且安全性较高.
A clinical comparison of open anatomical hepatectomy with different approaches for the treatment of hepatocellular carcinoma
Objective To compare the clinical efficacy of open anatomical hepatectomy using different approaches for the treatment of hepatocellular carcinoma(HCC).Methods This study was a prospective randomized controlled study.Sixty-four patients with HCC admitted to the hospital from January 2020 to January 2023 were included.According to the random number table method,the patients were divided into a control group(n=32 cases,the patients received conventional approach for open anatomical hepatectomy)and an observation group(n=32 cases,the patients received open anatomical hepatectomy along with the main hepatic vein approach).The peri-operative related indexes,liver function indexes,immune function indexes and inflammatory factors levels before and 7 days after operation were compared between the two groups,and the postoperative complications of the two groups were counted.Results The intra-operative blood loss in the control group was(324.44±76.73)mL,which was statistically significant different with that of(250.27±68.64)mL in the observation group(t=4.075,P<0.05).At 7 days after operation,the levels of aspartate aminotransferase,alkaline phosphatase,alanine aminotransferase and total bilirubin in the control group[(73.33±8.23)U/L,(94.44±9.19)U/L,(84.61±8.53)U/L and(24.39±2.64)μmol/L respectively]were higher than those in the observation group[(64.52±7.46)U/L,(94.44±9.19)U/L,(73.36±9.58)U/L and(22.14±2.96)μmol/L respectively,P<0.05].Three days after operation,the levels of IgA,IgG and IgM in the control group(1.71±0.23,8.31±1.53 and 1.21±0.28,respectively)were lower than those in the observation group(1.95±0.24,9.39±1.75 and 1.35±0.32,respectively,P<0.05).Three days after operation,the levels of serum interleukin-6,tumor necrosis factor-a,and C-reactive protein in the control group[(149.89±30.79)ng/L,(229.15±27.24)ng/L and(28.74±3.26)mg/L respectively]were higher than those in the observation group[(128.85±20.81)ng/L,(208.11±23.26)ng/L and(22.21±3.44)mg/L respectively,P<0.05].The total incidence of postoperative complications in the control group was 21.88%(7/32),while that in the observation group was 15.63%(5/32),without statistical significant difference(x2=0.410,P=0.522).Conclusion Compared with conventional approaches,the use of a main hepatic vein approach in patients with HCC can alleviate the liver damage and immune dysfunction caused by open anatomical hepatectomy,thus has a higher safety.

Main hepatic vein approachAnatomical hepatectomyHepatocellular carcinoma

王国峰、贾玉清、束长新、蔡晓东、王洪勃、徐件红

展开 >

225009 江苏 扬州大学医学院附属扬州友好医院普外科

肝静脉主干入路 解剖性肝脏切除术 肝细胞癌

2024

肝脏
上海市医学会

肝脏

CSTPCD
影响因子:0.71
ISSN:1008-1704
年,卷(期):2024.29(9)